Pages that link to "Q38038662"
Jump to navigation
Jump to search
The following pages link to Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function (Q38038662):
Displaying 22 items.
- Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors (Q24598747) (← links)
- Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease (Q34795541) (← links)
- Insulin therapy in people with type 2 diabetes: opportunities and challenges? (Q37461707) (← links)
- Early insulinization to prevent diabetes progression (Q37577178) (← links)
- Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis (Q38195430) (← links)
- Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps (Q38246691) (← links)
- Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? (Q38744831) (← links)
- Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation. (Q38749204) (← links)
- Pursuit of a perfect insulin. (Q38778988) (← links)
- Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes (Q39468025) (← links)
- Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes (Q41705110) (← links)
- Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes (Q42446656) (← links)
- Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. (Q42511731) (← links)
- Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery (Q47136824) (← links)
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes. (Q48189728) (← links)
- Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes. (Q48258498) (← links)
- Clinical effectiveness of Novolin® 30R versus Lantus® combined with Glucobay® treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: A randomized study (Q51320964) (← links)
- Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes (Q51322701) (← links)
- Practical application of short-term intensive insulin therapy based on the concept of "treat to target" to reduce hypoglycaemia in routine clinical site (Q89475403) (← links)
- Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes (Q90025604) (← links)
- Improved skeletal muscle energy metabolism relates to the recovery of β cell function by intensive insulin therapy in drug naïve type 2 diabetes (Q91939924) (← links)
- A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes (Q100959686) (← links)